⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Jodas Expoim Private Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Jodas Expoim Private Limited
↗Hyderabad, India
Jodas Expoim is a global, specialty, innovation-driven pharmaceutical company based in Hyderabad, India. Founded in 2006, the company specializes in the development and manufacturing of chemotherapeutic agents, cytotoxic drugs, and other specialty formulations, with a strong focus on oncology, contrast media, and critical care products.
The company operates state-of-the-art manufacturing facilities and maintains a significant global footprint, with approved products in over 50 countries. Jodas Expoim is recognized for its commitment to high-quality, affordable generic formulations and is actively expanding its capabilities in biosimilars and novel biopharmaceuticals.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Oncology, Contrast Media, Critical Care
SIZE & FINANCIALS
Employees:501-1000
Revenue:$72.4M
Founded:2006
Ownership:private
Status:operating
FUNDING
Stage:Private
Investors:BIRAC
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Biosimilars, Injectables
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Apollo Pharma GmbH
COMPETITION
Position:Emerging
Competitors:Novartis, Catalent, Biotage, Aurobindo Pharma, Wockhardt
LEADERSHIP
Key Executives:
Jyoti Loomba - Chief Managing Director
Satyendra Kumar Singh - Managing Director
Shashi Shanker Parsad Singh - Managing Director
Scientific Founders:Satyendra Kumar Singh, Shashi Shanker Parsad Singh
LINKS
Website:jodasexpoim.in
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Jodas Expoim Private Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.